Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.sequent.in | |
Market Cap | 2,875.97 Cr. | |
Enterprise Value(EV) | 3,236.18 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -5.15 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.46 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 25.75 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 4.48 | Calculated using Price: 115.30 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 24.94 Cr. | 249,433,495 Shares |
FaceValue | 2 | |
About Sequent Scientific Ltd. | ||
Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd. Pursuant to the Scheme of Amalgamation as approved by the Honourable High Court Bombay vide its order dated June 16, 2009 Company made requisite application to the Registrar of Companies Mumbai for change of its name from PI Drugs & Pharmaceuticals Ltd. to Sequent Scientific Ltd. Accordingly Registrar of Companies approved the application and issued fresh Certificate of Incorporation consequent upon change in name dated October 27, 2009 and with effect from the date the name of Company changed to Sequent Scientific Ltd. |
1 Day |
|
-3.72% |
1 Week |
|
+2.17% |
1 Month |
|
-16.72% |
3 Month |
|
-1.75% |
6 Month |
|
+23.53% |
1 Year |
|
+68.67% |
2 Year |
|
-14.50% |
5 Year |
|
+59.70% |
10 Year |
|
+211.45% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -159.4 | -3.67 | -1.47 | 1.28 | 8.63 | 12.06 | 15 | 6.56 | -18.95 | |
Return on Capital Employed (%) | -3.91 | 2.5 | 1.05 | 4.84 | 9.24 | 12.59 | 16.24 | 7.01 | -9.71 | |
Return on Assets (%) | -8.62 | -1.46 | -0.81 | 0.63 | 4.14 | 5.73 | 7.19 | 3.06 | -7.99 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 91 | 946 | 977 | 648 | 707 | 687 | 728 | 692 | 699 | 632 | |
Non Curr. Liab. | 278 | 300 | 246 | 227 | 215 | 216 | 154 | 209 | 258 | 149 | |
Curr. Liab. | 406 | 290 | 545 | 431 | 440 | 515 | 513 | 537 | 559 | 602 | |
Minority Int. | 147 | 2 | 17 | 37 | 40 | 45 | 49 | 48 | 50 | 51 | |
Equity & Liab. | 922 | 1,538 | 1,904 | 1,343 | 1,402 | 1,463 | 1,443 | 1,487 | 1,566 | 1,434 | |
Non Curr. Assets | 612 | 1,047 | 1,176 | 805 | 796 | 739 | 676 | 678 | 743 | 661 | |
Curr. Assets | 310 | 476 | 594 | 538 | 606 | 724 | 767 | 808 | 812 | 773 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 922 | 1,538 | 1,904 | 1,343 | 1,402 | 1,463 | 1,443 | 1,487 | 1,566 | 1,434 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 443 | 606 | 684 | 848 | 1,039 | 1,179 | 1,362 | 1,413 | 1,421 | 1,375 | |
Other Income | 10 | 13 | 11 | 17 | 9 | 10 | 10 | 11 | 6 | 9 | |
Total Income | 453 | 620 | 695 | 864 | 1,048 | 1,189 | 1,372 | 1,424 | 1,427 | 1,384 | |
Total Expenditure | -425 | -551 | -641 | -765 | -914 | -1,009 | -1,152 | -1,303 | -1,409 | -1,349 | |
PBIDT | 28 | 68 | 54 | 100 | 134 | 180 | 220 | 120 | 18 | 34 | |
Interest | -43 | -38 | -28 | -33 | -33 | -36 | -24 | -16 | -36 | -47 | |
Depreciation | -32 | -46 | -40 | -41 | -42 | -51 | -51 | -52 | -56 | -60 | |
Taxation | -3 | -3 | 1 | -13 | -2 | -12 | -32 | -8 | 16 | 23 | |
Exceptional Items | -17 | -2 | -9 | -65 | -74 | ||||||
PAT | -67 | -18 | -14 | 10 | 57 | 82 | 104 | 45 | -122 | -123 | |
Minority Interest | 1 | -2 | 3 | -9 | -8 | -12 | -9 | -4 | 1 | -5 | |
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | -11 | -18 | -14 | 422 | 49 | 70 | 95 | 41 | -121 | -129 | |
Adjusted EPS | -1 | -1 | -1 | 17 | 2 | 3 | 4 | 2 | -5 | -5 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -45 | -24 | 0 | -7 | 45 | 116 | 115 | 115 | 31 | 17 | |
Cash Fr. Inv. | -80 | -155 | -316 | -116 | 7 | -68 | -72 | 10 | -96 | -65 | |
Cash Fr. Finan. | 146 | 179 | 309 | 147 | -57 | -20 | -43 | -139 | 67 | 32 | |
Net Change | 21 | 1 | -7 | 24 | -5 | 28 | 0 | -14 | 2 | -16 | |
Cash & Cash Eqvt | 23 | 22 | 20 | 44 | 40 | 68 | 68 | 54 | 58 | 42 |
Mon, 11 Mar 2024
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report Voting Results of Postal ballot pursuant to regulation 44 of the SEBI (Listing obligation and disclosure requirements) Regulations 2015 and Scrutinizers Report |
Mon, 11 Mar 2024
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report Voting Results of Postal ballot pursuant to regulation 44 of the SEBI (Listing obligation and disclosure requirements) Regulations 2015 and Scrutinizers Report |
Thu, 22 Feb 2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript Intimation of Earnings Call Transcript as per Regulation 30 of SEBI (LODR) Regulations 2015 |
Thu, 28 Mar 2024 |
Close Below Last Month Low |
High Decrease in 1 Month |
High Increase in 6 Months |
High Increase in 1 Year |
MFI Trending Up |